UK Markets closed

Compugroup Medical SE & Co. KGaA (0MSD.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
66.20+2.20 (+3.44%)
At close: 5:50PM BST
Currency in EUR

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 33.68B
Trailing P/E 54.58
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)5.29
Enterprise value/revenue 34.70
Enterprise value/EBITDA 623.97

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 366.55
52-week low 364.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Float 24.16M
% held by insiders 150.58%
% held by institutions 120.86%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.50
Trailing annual dividend yield 30.78%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020


Profit margin 7.72%
Operating margin (ttm)15.33%

Management effectiveness

Return on assets (ttm)6.37%
Return on equity (ttm)14.13%

Income statement

Revenue (ttm)783.46M
Revenue per share (ttm)16.26
Quarterly revenue growth (yoy)0.20%
Gross profit (ttm)292.03M
EBITDA 153.67M
Net income avi to common (ttm)60.46M
Diluted EPS (ttm)1.21
Quarterly earnings growth (yoy)16.80%

Balance sheet

Total cash (mrq)365.25M
Total cash per share (mrq)7.61
Total debt (mrq)467.77M
Total debt/equity (mrq)77.81
Current ratio (mrq)2.34
Book value per share (mrq)12.52

Cash flow statement

Operating cash flow (ttm)79.74M
Levered free cash flow (ttm)48.15M
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more